Cite

HARVARD Citation

    Xiao, S. et al. (n.d.). MiR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling. Oncogenesis. pp. 1-13. [Online]. 
  
Back to record